January - 2021

Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma

Now, a group of scientists at Children's Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting...

Landmark research toward increasing survival rates for aggressive childhood cancer

A new combination of drugs could help to increase survival rates with fewer side effects for some children with one of the most...

FDA Approves Crizotinib for Pediatric ALK+ ALCL Indication

Crizotinib—a tyrosine kinase inhibitor with activity against ALK, ROS1, and MET—was granted FDA approval for use in pediatric patients ...

Drug combination increases susceptibility to chemotherapy in cases of severe neuroblastoma

Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a...

Fermanagh scientist leads breakthrough on childhood cancer research

A scientist from Kinawely now based in Amsterdam has led a breakthrough discovery in childhood cancer research. Dr. Caitrín Crudden is a...

Parents' finances differently affected by having a child diagnosed with cancer

Mothers and fathers of children diagnosed with cancer are affected financially in different ways. While mothers' incomes fall in the...

Pediatric Cancer Survivors Treated With Abdominopelvic RT Have Higher Risk of CRC

Study shows potential of new treatment strategies for most common childhood cancer

Promising target for CAR T cells helps cancer trick the immune system

Palliative Care Important for Young Patients During ‘Identity Development’

Scientists discover new Achilles heel of leukemia cells

Promising investigational therapy improves survival in aggressive childhood brain tumor

Childhood cancer mortality has fallen significantly in the US, but disparities have emerged

St. Jude scientists identify T-cell differentiation nodes to improve cancer-killing

Analysis shows high rate of ‘significant’ health problems in childhood cancer survivors

Fusion oncoprotein forces cell fates toward rhabdomyosarcoma